Shareholding disclosure

Bank of America Corporation

Declared position

3.083%

Threshold

Crossed upwards

Timeline

Published

19.01.2022

Transaction

12.01.2022

Transfer date

12.01.2022

Voting rights breakdown

Voting rights acquired3.083%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM1I00017

Beneficial owner

Bank of America Corporation

Declared address

Bank of America Corporation, Wilmington, DE 19801

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Bank of America Corporation

Santhera Pharmaceuticals Holding AG19.01.2022TAM1I00017

Disclosure summary

Bank of America Corporation disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 19.01.2022, at 3.083% of voting rights. Notice category: Single shareholder.

Disclosed position

3.083%

Voting rights acquired

Voting rights acquired3.083%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Bank of America Corporation disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 19.01.2022.

Publication date19.01.2022

Transaction date12.01.2022

Transfer date12.01.2022

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerBank of America Corporation

Declared addressBank of America Corporation, Wilmington, DE 19801

CategorySingle shareholder

Voting rights acquired3.083%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAM1I00017

Source: SIX Exchange Regulation · Publication date: 19.01.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open